Benzinga | Jan 5, 2022 07:08AM EST

Kiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Brian M Strem, Ph.D., President and Chief Executive Officer, will provide an outlook for the busines and its pipeline of treatments for ophthalmic diseases.

The corporate presentation will be available on-demand and accessible from the Company's Investor Relations website starting Monday January 10, 2022 at 7:00 am Eastern Time.